Abstract #3601

MR-guided focal laser ablation as primary treatment for prostate cancer: Preliminary results

Joyce GR Bomers¹, Christiaan G Overduin¹, Sjoerd FM Jenniskens¹, Michiel Sedelaar², and Jurgen J Futterer¹

¹Radiology, Radboud University Medical Center, Nijmegen, Netherlands, ²Urology, Radboud University Medical Center, Nijmegen, Netherlands

Focal therapy offers great hopes in terms of cancer control and decreased morbidity (i.e. impotence and incontinence) for patients with localized for low- and intermediate grade prostate cancer (PCa). Transrectal MR-guided focal laser ablation of newly diagnosed PCa was successfully performed in 5 patients. It was technically feasible and safe. PSA level decreased in all patients and follow-up MRI showed no residual or recurrent cancer; indicating local cancer control, without compromising with increased morbidity or a decrease in quality of life. Initial results are promising and more patients have to be included with longer follow-up.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.